Now I have all the information needed. Let me produce the final consolidated review.

## Summary

The paper introduces the problem of PPI candidate ranking — given a target protein and its known interaction partners, rank novel candidates most likely to be future experimentally validated interactions. The authors propose a two-stage framework: (1) interpretability-guided retrieval that uses predicted contact maps from D-SCRIPT/Topsy-Turvy to select active residue regions of known partners, then computes cosine similarity between those regions and sliding windows over candidate proteins; (2) a re-ranking module that integrates interaction scores, structural plausibility (pDockQ), functional annotations, and LLM-based semantic similarity. The evaluation uses a prospective temporal split (STRING v11 → v12), demonstrating substantial improvements over raw interaction probability rankings.

## Strengths

- **Prospective temporal evaluation design.** Using STRING v11 as known data and v12 as a held-out future set (Section 5.1) is a realistic, temporally correct evaluation that avoids common leakage in static benchmarks. This is a genuine methodological strength.
- **Large-scale evaluation with substantial improvements.** Table 1 reports retrieval metrics across 279,568 novel interactions, showing that the interpretability-guided retrieval improves Recall@10 for D-SCRIPT from 0.0124 (raw probability) to 0.2641, and MRR from 0.0340 to 0.1685. These are practically meaningful gains for directing experimental resources.
- **Interpretability-guided retrieval mechanism.** The idea of using predicted contact-map activations (Section 4.1, Eq. 3–4) to focus similarity computations on the most informative residue regions of known partners is a concrete and novel technical contribution.
- **Multi-source re-ranking with complementarity analysis.** Table 2 provides a systematic pairwise comparison of ten evidence sources, showing which signals are complementary. This is informative for practitioners designing prioritization pipelines.

## Weaknesses

### Major

1. **Missing baselines that use known-partner information (merged from Critic 1 & 2).** The central comparison in Table 1 pits the proposed method (which exploits known partners KP(p) as anchors) against raw D-SCRIPT, Topsy-Turvy, and xCAPT5 interaction probabilities applied directly to (p, p_c) pairs. Those baselines do *not* use any information about known partners. The claimed gains (e.g., Recall@10 from ~1% to ~26%) conflate two factors: the use of known-partner information *per se* and the specific active-residue selection mechanism. The paper needs baselines that incorporate known partners in straightforward ways — for instance, ranking candidates by the maximum D-SCRIPT score with any known partner, or by cosine similarity between full embeddings of known partners and candidates (without contact-map masking). Without these controls, it is impossible to attribute the improvement to the active-residue selection or to the interpretability-guided alignment rather than merely to the aggregation over anchors. This directly undermines the claimed novelty of the retrieval stage.

2. **Re-ranking evaluation is incomplete.** The re-ranking module (Section 4.2) is presented as an integral part of the framework, yet the paper never reports end-to-end ranking metrics after re-ranking. Table 2 only shows pairwise rank-shift comparisons (e.g., "75.5% of interactions maintain or improve when switching from Cosine to PubMedBERT"). It does not indicate whether the final re-ranked list improves over the initial retrieval in terms of Recall@k, MRR, or any other global measure. The reader cannot assess whether the additional signals (LLMs, pDockQ, etc.) actually sharpen the ranking, or merely shuffle candidates without net benefit. Given that the paper states "we show that this step is crucial to refine the initial embedding-based ranking" (Section 1), the absence of end-to-end evaluation is a significant gap.

### Minor

3. **Overstated "two orders of magnitude" claim.** The Abstract and Introduction claim improvements "by two orders of magnitude." The actual improvements in Table 1 are roughly 20–30× on early recall (e.g., Recall@10: 0.0124 → 0.2641, ~21×) and ~5× on MRR. 20–30× is one order of magnitude, not two. While the improvements are still substantial, the phrasing misrepresents the magnitude.

4. **Potential label leakage in PubMedBERT fine-tuning (limited scope).** The cross-encoder (Section 4.2) is trained on STRING v11 pairs, with negative pairs sampled from non-interacting protein pairs. Novel v12 interactions that were not present in v11 could theoretically appear among the negative training samples if randomly drawn. This would mean the model was trained to assign low scores to some of the very interactions it is later asked to rank. While the probability of any specific v12 pair being sampled is low, this is a subtle issue that should be acknowledged and analyzed. The paper does not discuss this.

5. **Active-residue selection not validated against biological interfaces.** The method selects the contiguous segment with highest average contact-map activation (Section 4.1) as the "most stable and informative interaction region." No analysis is provided to show that these segments correspond to known binding interfaces (e.g., from PDB complexes) or are biologically plausible. While the paper acknowledges this partially in the limitations (Section 6), the interpretability framing would be stronger with some validation.

### Trivial

6. **Minor imprecisions in the text.** Several formatting artifacts and small inconsistencies (e.g., "a the two-stage framework", "Both baselines recover and xCAPT5" — a garbled sentence). These are parser artifacts in the extracted text but presumably reflect some original issues.

## Nice-to-Have

- **Analysis of active-residue regions.** Providing case studies or quantitative statistics showing whether the selected contiguous segments align with known binding interfaces would substantially strengthen the interpretability claim.
- **Impact of known-partner count.** The paper's limitations mention that the method may not work well for proteins with few known partners, but this is not quantified. An analysis of retrieval performance stratified by |KP(p)| would be informative.
- **End-to-end re-ranking metrics.** Reporting Recall@k, MRR, and Success@k after the re-ranking step (e.g., cosine retrieval + PubMedBERT re-ranking) would complete the evaluation.

## Removed Points

- **Criticism about "missing hyperparameters" (appendix details).** The paper states that "Details of experimental setup and parameter choices are reported in Appendix A.1." The appendix is stripped by the parser; this is a known artifact, not a paper flaw.
- **Criticism about rank-shift table being "difficult to interpret."** The table is interpretable and accompanied by a clear textual discussion (Section 5.3). The maintain/improve fraction is a standard and appropriate metric for this analysis.
- **Criticism about "no end-to-end analysis."** Retained under Major (Weakness 2); the individual formatting complaints were removed.
- **Strength Finder's generic strengths** (e.g., "the paper addressed an important problem"). These are dropped as they lack specific evidence.

## Novel Insights

None beyond the paper's own contributions. The reviews surface the known-partner baseline gap as the central issue, which is not identified in the paper itself.

## Suggestions

1. **Add simple known-partner baselines** to Table 1: (a) rank candidates by max D-SCRIPT/Topsy-Turvy interaction score over all known partners; (b) rank candidates by cosine similarity between full (unmasked) embeddings of known partners and candidates. This will isolate the effect of the active-residue selection.
2. **Report end-to-end metrics** after applying the re-ranking step (e.g., cosine retrieval + PubMedBERT) at the same cutoffs (k=5,10,50,100,200,500) used in Table 1.
3. **Add a case study** showing the predicted contact map, selected active residues, and how the sliding-window alignment matches against a true novel partner, to make the mechanism concrete.
4. **Correct the "two orders of magnitude" claim** to reflect the actual magnitude of improvement (~20× on early recall, ~5× on MRR).
5. **Analyze the PubMedBERT label issue** explicitly — quantify the overlap between v12 positives and v11 negative training samples, or clarify that the negative sampling procedure prevents this overlap.

## Score and Decision

**Anchor comparison:**

| Anchor | Path | Avg Score | Comparison |
|--------|------|-----------|------------|
| LLaPA (PPI-LLM) | eh1fL0zw8o.md | 6.00 | Similar baseline-comparison issues but stronger LLM justification; this paper has a cleaner temporal evaluation |
| MAPE-PPI | itGkF993gz.md | 5.67 | Stronger methodological novelty in embedding learning; this paper has a broader framework but weaker ablation |
| PPIformer | xcMmebCT7s.md | 5.80 | Cleaner evaluation with better controls; this paper has more ambitious framing but messier evaluation |
| ProtIR (function pred.) | jsQPjIaNNh.md | 5.25 | Similar missing-baseline issues; this paper has stronger data and clearer problem framing |
| Leakage-free splitting | ifK9NFyrhn.md | 3.50 | Niche contribution, less relevant; this paper is substantially stronger |

The paper has a genuine contribution (PPI candidate ranking with temporal evaluation, interpretability-guided retrieval) but the evaluation is weakened by the absence of baselines that incorporate known-partner information. Without these, it is unclear whether the improvement comes from the claimed active-residue selection or simply from using known partners at all. The incomplete re-ranking evaluation further limits the assessment. The paper requires major revisions but the core ideas are promising.

MY FINAL SCORE: <score>5.0</score>
MY FINAL DECISION: <decision>Reject</decision>